- Article
Cancer Vaccines Co-Targeting HER2/Neu and IGF1R
- Carla De Giovanni,
- Lorena Landuzzi,
- Arianna Palladini,
- Marianna Lucia Ianzano,
- Giordano Nicoletti,
- Francesca Ruzzi,
- Augusto Amici,
- Stefania Croci,
- Patrizia Nanni and
- Pier-Luigi Lollini
(1) Background: Human epidermal growth factor receptor 2 (HER2)/neu-driven carcinogenesis is delayed by preventive vaccines able to elicit autochthonous antibodies against HER2/neu. Since cooperation between different receptor tyrosine kinases (RTKs)...